Get our Free Patent Expiration Newsletter

Serving hundreds of leading biopharmaceutical companies globally:

Cantor Fitzgerald
Julphar
Chinese Patent Office
Merck
Citi
Healthtrust

Generated: September 19, 2019

DrugPatentWatch Database Preview

Patent: 7,718,702

  Try a free trial


See Plans and Pricing

« Back to Dashboard

Summary for Patent: 7,718,702
Title:Cannabinoid receptor ligands
Abstract: There are disclosed compounds of the formula ##STR00001## a prodrug thereof, or a pharmaceutically acceptable salt, solvate or stereoisomer of the compound or of said prodrug; which exhibit anti-inflammatory and immunodulatory activity. Also disclosed are pharmaceutical compositions containing said compounds and methods of using the compounds for the treatment of various diseases and conditions.
Inventor(s): Kozlowski; Joseph A. (Princeton, NJ), Shih; Neng-Yang (North Caldwell, NJ), Lavey; Brian J. (Chatham, NJ), Rizvi; Razia K. (Bloomfield, NJ), Shankar; Bandarpalle B. (Branchburg, NJ), Spitler; James M. (Westfield, NJ), Tong; Ling (Warran, NJ), Wolin; Ronald L. (San Diego, CA), Wong; Michael K. (North Brunswick, NJ)
Assignee: Schering Corporation (Kenilworth, NJ)
Application Number:11/203,946
Patent Claims:see list of patent claims

Details for Patent 7,718,702

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Novartis SIMULECT basiliximab VIAL; SINGLE-USE 103764 001 1998-05-12 ➤ Sign Up Schering Corporation (Kenilworth, NJ) 2021-02-08 RX search
Novartis SIMULECT basiliximab VIAL; SINGLE-USE 103764 002 1998-05-12 ➤ Sign Up Schering Corporation (Kenilworth, NJ) 2021-02-08 RX search
Centocor Inc REMICADE infliximab VIAL 103772 001 1998-08-24 ➤ Sign Up Schering Corporation (Kenilworth, NJ) 2021-02-08 RX Orphan search
Immunex ENBREL etanercept VIAL; SUBCUTANEOUS 103795 001 1998-11-02 ➤ Sign Up Schering Corporation (Kenilworth, NJ) 2021-02-08 RX Orphan search
Immunex ENBREL etanercept SYRINGE 103795 002 1998-11-02 ➤ Sign Up Schering Corporation (Kenilworth, NJ) 2021-02-08 RX Orphan search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

UBS
McKesson
Johnson and Johnson
QuintilesIMS
Teva
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.